56 related articles for article (PubMed ID: 2851965)
1. [Treatment of acute pulmonary embolism with a low molecular weight heparin by the intravenous route. Study of the optimal dosage].
Quilliet L; Charbonnier B; Delahousse B; Gruel Y; Brochier ML; Leroy J; Toulemonde F
Arch Mal Coeur Vaiss; 1988 Oct; 81(10):1219-25. PubMed ID: 2851965
[TBL] [Abstract][Full Text] [Related]
2. Prophylaxis of fatal pulmonary embolism in general surgery using low-molecular weight heparin Cy 216: a multicentre, double-blind, randomized, controlled, clinical trial versus placebo (STEP). STEP-Study Group.
Pezzuoli G; Neri Serneri GG; Settembrini P; Coggi G; Olivari N; Buzzetti G; Chierichetti S; Scotti A; Scatigna M; Carnovali M
Int Surg; 1989; 74(4):205-10. PubMed ID: 2560470
[TBL] [Abstract][Full Text] [Related]
3. [Use in hemodialysis and hemofiltration of CY 216 (Fraxiparine) administered via intravenous bolus in patients with acute and chronic renal insufficiency with and without hemorrhagic risk].
Steinbach G; Bosc C; Caraman PL; Azoulay E; Olry L; D'Azemar P; Chopin J
Nephrologie; 1990; 11(1):17-21. PubMed ID: 2165223
[TBL] [Abstract][Full Text] [Related]
4. Comparison of 3,000 IU aXa of the low molecular weight heparin certoparin with 5,000 IU aXa in prevention of deep vein thrombosis after total hip replacement. German Thrombosis Study Group.
Adolf J; Fritsche HM; Haas S; Hennig FF; Horbach T; Kastl S; Koppenhagen K; Michaelis HC; Rhamanzadeh R; Summa W; Wagner W; Weber U; Wolf H
Int Angiol; 1999 Jun; 18(2):122-6. PubMed ID: 10424367
[TBL] [Abstract][Full Text] [Related]
5. Low molecular weight heparin (dalteparin) is equally effective as unfractionated heparin in reducing coagulation activity and perfusion abnormalities during the early treatment of pulmonary embolism.
Schutgens RE; Esseboom EU; Snijder RJ; Haas FJ; Verzijlbergen F; Nieuwenhuis HK; Lisman T; Biesma DH
J Lab Clin Med; 2004 Aug; 144(2):100-7. PubMed ID: 15322504
[TBL] [Abstract][Full Text] [Related]
6. [Prophylactic and therapeutic use of a low molecular weight heparin fraction, CY 216].
Roussi J; Houbouyan L; Tereschenko C; Alterescu R; François D; Toulemonde F; Goguel A
J Mal Vasc; 1987; 12 Suppl B():123-7. PubMed ID: 2834483
[TBL] [Abstract][Full Text] [Related]
7. Subcutaneous low-molecular-weight heparin fragmin versus intravenous unfractionated heparin in the treatment of acute non massive pulmonary embolism: an open randomized pilot study.
Meyer G; Brenot F; Pacouret G; Simonneau G; Gillet Juvin K; Charbonnier B; Sors H
Thromb Haemost; 1995 Dec; 74(6):1432-5. PubMed ID: 8772215
[TBL] [Abstract][Full Text] [Related]
8. Suppression of intimal hyperplasia with low molecular weight heparin in a sheep model.
Ao PY; Hawthorne WJ; Coombs R; Fletcher JP
Int Angiol; 1999 Jun; 18(2):131-9. PubMed ID: 10424369
[TBL] [Abstract][Full Text] [Related]
9. Subcutaneous low-molecular-weight heparin compared with continuous intravenous unfractionated heparin in the treatment of proximal deep vein thrombosis.
Simonneau G; Charbonnier B; Decousus H; Planchon B; Ninet J; Sie P; Silsiguen M; Combe S
Arch Intern Med; 1993 Jul; 153(13):1541-6. PubMed ID: 8391792
[TBL] [Abstract][Full Text] [Related]
10. A comparative double-blind, randomised trial of a new second generation LMWH (bemiparin) and UFH in the prevention of post-operative venous thromboembolism. The Bemiparin Assessment group.
Kakkar VV; Howes J; Sharma V; Kadziola Z
Thromb Haemost; 2000 Apr; 83(4):523-9. PubMed ID: 10780310
[TBL] [Abstract][Full Text] [Related]
11. [Anticoagulation in hemodialysis sessions with a low molecular weight heparin (CY 222, Choay). Dosage studies in chronic hemodialysis. Its use in patients at high risk of hemorrhage].
Dieval J; Morinière P; Roussel B; Bayrou B; Fournier A; Delobel J
J Mal Vasc; 1987; 12 Suppl B():114-8. PubMed ID: 2834482
[TBL] [Abstract][Full Text] [Related]
12. Suboptimal doses of low molecular weight heparin and acute venous thromboembolism. Data from the RIETE registry.
Bruscas MJ; Nieto JA; Perez-Pinar M; López-Jiménez L; Fernández-Capitán C; López-Chuliá F; Orue-Lecue MT;
Ann Hematol; 2007 Jul; 86(7):519-26. PubMed ID: 17437112
[TBL] [Abstract][Full Text] [Related]
13. [Treatment of acute pulmonary embolism with urokinase compared with the combination plasminogen-urokinase. Apropos of 67 cases].
François G; Charbonnier B; Raynaud P; Garnier LF; Griguer P; Brochier M
Arch Mal Coeur Vaiss; 1986 Apr; 79(4):435-42. PubMed ID: 3090961
[TBL] [Abstract][Full Text] [Related]
14. Prevention of fatal pulmonary embolism and mortality in surgical patients: a randomized double-blind comparison of LMWH with unfractionated heparin.
Haas S; Wolf H; Kakkar AK; Fareed J; Encke A
Thromb Haemost; 2005 Oct; 94(4):814-9. PubMed ID: 16270636
[TBL] [Abstract][Full Text] [Related]
15. Low-molecular-weight heparin in the treatment of pulmonary embolism.
Ageno W; Turpie AG
Semin Vasc Surg; 2000 Sep; 13(3):189-93. PubMed ID: 11005462
[TBL] [Abstract][Full Text] [Related]
16. [Use of a low molecular weight heparin, CY 222, in the treatment of consumption coagulopathy].
Audibert G; Lambert H; Toulemonde F; Alexandre P; Laprevote-Heully MC; Bollaert PE; Bauer P; Larcan A
J Mal Vasc; 1987; 12 Suppl B():147-51. PubMed ID: 2834489
[TBL] [Abstract][Full Text] [Related]
17. Comparison of unfractionated heparin vs low molecular weight heparin in the treatment of acute deep vein thrombosis.
Naz R; Naz S; Mehboob M; Khalid GH
J Coll Physicians Surg Pak; 2005 Oct; 15(10):601-4. PubMed ID: 19810295
[TBL] [Abstract][Full Text] [Related]
18. [Plasma exchange with very low molecular weight heparin CY 222. Biological profile and therapeutic value].
Assogba U; Crespo B; Bayrou B; Binet JL; Rottembourg J
Ann Med Interne (Paris); 1988; 139 Suppl 1():66-8. PubMed ID: 2854713
[TBL] [Abstract][Full Text] [Related]
19. Subcutaneous adjusted-dose unfractionated heparin vs fixed-dose low-molecular-weight heparin in the initial treatment of venous thromboembolism.
Prandoni P; Carnovali M; Marchiori A;
Arch Intern Med; 2004 May; 164(10):1077-83. PubMed ID: 15159264
[TBL] [Abstract][Full Text] [Related]
20. Randomized trial of subcutaneous low-molecular-weight heparin CY 216 (Fraxiparine) compared with intravenous unfractionated heparin in the curative treatment of submassive pulmonary embolism. A dose-ranging study.
Théry C; Simonneau G; Meyer G; Hélénon O; Bridey F; Armagnac C; d'Azemar P; Coquart JP
Circulation; 1992 Apr; 85(4):1380-9. PubMed ID: 1313340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
